fp-045
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 26, 2018 (NCT03686930)
Timeline
Indications
Mechanism of action
- Aldehyde dehydrogenaseACTIVATOR
ALDH2 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06475781 | Phase 2 | Dec 31, 2024 | Foresee Pharmaceuticals Co., Ltd. |
| NCT04522375 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2020 | Foresee Pharmaceuticals Co., Ltd. |
| NCT03686930 | Phase 1 | Feb 26, 2018 | Foresee Pharmaceuticals Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Foresee Pharmaceuticals Co., Ltd. | For profit | 3 | 3 | 2 | 2018 |
1 organizations
Page 1 / 1